Molly Quinlan
Family · Golden, CONPI 1588211486
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations.
Across 61 payments — averaging $21.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$263
- Mayne Pharma Commercial LLC$208
- Evofem Biosciences, Inc.$110
- Astellas Pharma US Inc$107
- C. R. Bard, Inc. & Subsidiaries$81
- Sumitomo Pharma America, Inc.$66
- plus $467 from 14 others
What the payments were for
- Food & beverage$1,302100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $263 |
| Mayne Pharma Commercial LLC | 8 | $208 |
| Evofem Biosciences, Inc. | 6 | $110 |
| Astellas Pharma US Inc | 5 | $107 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $81 |
| Sumitomo Pharma America, Inc. | 3 | $66 |
| Pfizer | 3 | $66 |
| Exeltis, USA Inc. | 3 | $65 |
| Exact Sciences | 3 | $65 |
| Myovant Sciences Inc. | 2 | $44 |
| Organon | 2 | $39 |
| Therapeuticsmd, Inc. | 2 | $32 |
| Coopersurgical, Inc. | 2 | $30 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Avion Pharmaceuticals | 1 | $20 |
| Bayer | 1 | $19 |
| Ascend Therapeutics US, LLC | 1 | $18 |
| Visby Medical, Inc. | 1 | $17 |
| Shield Therapeutics Inc | 1 | $16 |
| Acella Pharmaceuticals, LLC | 1 | $14 |
How this compares
$1,302 in reported general payments places this provider in the 80th percentile of 2,182 family providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 17 | $2,010 |
| Estradiol (Twice Weekly)Estradiol | 12 | $1,136 |
| ProgesteroneProgesterone, Micronized | 17 | $488 |
Paid to pharmacies, not to this prescriber.
Other family in Golden
- Corinne YoungColorado Springs$272K
- Margaret MachaffieColorado Springs$97K
- April RossGrand Junction$95K
- Jeannette LillerColorado Springs$74K
- Teal MeffordThornton$63K
- Jacquita JordanColorado Springs$52K
- Stephanie HanenbergColorado Springs$40K
- Courtney WeirFort Collins$30K
- Katie NadingDenver$28K
- Randall McDavidDenver$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.